Thrombosis Journal (Jun 2022)

Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background

  • Pauline C. S. van Paridon,
  • Marina Panova-Noeva,
  • Rene van Oerle,
  • Andreas Schulz,
  • Jürgen H. Prochaska,
  • Natalie Arnold,
  • Irene Schmidtmann,
  • Manfred Beutel,
  • Norbert Pfeiffer,
  • Thomas Münzel,
  • Karl J. Lackner,
  • Hugo ten Cate,
  • Philipp S. Wild,
  • Henri M. H. Spronk

DOI
https://doi.org/10.1186/s12959-022-00392-0
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background The current study aims to identify the relationships between coagulation factors and plasma thrombin generation in a large population-based study by comparing individuals with a history of arterial or venous thrombosis to cardiovascular healthy individuals. Methods This study comprised 502 individuals with a history of arterial disease, 195 with history of venous thrombosis and 1402 cardiovascular healthy individuals (reference group) from the population-based Gutenberg Health Study (GHS). Calibrated Automated Thrombography was assessed and coagulation factors were measured by means of BCS XP Systems. To assess the biochemical determinants of TG variables, a multiple linear regression analysis, adjusted for age, sex and antithrombotic therapy, was conducted. Results The lag time, the time to form the first thrombin, was mainly positively associated with the natural coagulant and anti-coagulant factors in the reference group, i.e. higher factors result in a longer lag time. The same determinants were negative for individuals with a history of arterial or venous thrombosis, with a 10 times higher effect size. Endogenous thrombin potential, or area under the curve, was predominantly positively determined by factor II, VIII, X and IX in all groups. However, the effect sizes of the reported associations were 4 times higher for the arterial and venous disease groups in comparison to the reference group. Conclusion This large-scale analysis demonstrated a stronger effect of the coagulant and natural anti-coagulant factors on the thrombin potential in individuals with a history of arterial or venous thrombosis as compared to healthy individuals, which implicates sustained alterations in the plasma coagulome in subjects with a history of thrombotic vascular disease, despite intake of antithrombotic therapy.

Keywords